Healthcare Microfluidics Market 2020 Strategic Assessments - Abbott Laboratories, Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Danaher Corporation, Roche

The Healthcare Microfluidics Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The field of microfluidics uses microfabrication to create miniaturized devices to handle fluids. The field of microfluidics has four parents: molecular analysis, biodefence, molecular biology and microelectronics. Advances in microfluidics technology are revolutionizing molecular biology procedures for enzymatic analysis (glucose and lactate assays), DNA analysis (polymerase chain reaction and high-throughput sequencing), and proteomics.

Buy The Report:
https://www.marketinsightsreports.com/report/purchase/01231062613?mode=su?source=openpr&Mode=12

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Healthcare Microfluidics Market: Abbott Laboratories, Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Danaher Corporation, Roche, IDEX Corporation, PerkinElmer, Thermo Fisher Scientific and others.

Industry News:

ABBOTT PARK, Ill., March 27, 2020: Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes. The test will run on the company's ID NOW(TM) platform, providing rapid results in a wide range of healthcare settings such as physicians' offices, urgent care clinics and hospital emergency departments.

The ID NOW platform is small, lightweight (6.6 pounds) and portable (the size of a small toaster), and uses molecular technology, which is valued by clinicians and the scientific community for its high degree of accuracy. ID NOW is already the most widely available molecular point-of-care testing platform in the U.S. today.

30 March 2020: SANTA CLARA, Calif: Agilent Technologies Inc. (NYSE: A) today introduced the Agilent K6460S Clinical Edition TQ LC/MS system, designed to improve in vitro diagnostic workflows in clinical labs. Agilent's next-generation clinical edition triple quadrupole LC/MS system, the K6460S, is listed as a Class I medical device with the U.S. Food and Drug Administration. The system includes a preconfigured liquid chromatograph and mass spectrometer, as well as the clinical edition of Agilent MassHunter software, which provides an easy-to-use and intuitive submission-to-reporting workflow. When performing diagnostic assays, the K6460S provides the specificity and selectivity that clinical labs require, delivering robust results with more accuracy, and increasing the reliability of target compound detection in complex matrices.

Global Healthcare Microfluidics Market Split by Product Type and Applications:

This report segments the market on the basis of Types are:
Glass Based
Polymer Based
Silicon Based
Others

On the basis of Application, the market is segmented into:

Homecare
Hospitals
Others

Click the link to get a Sample Copy of the Report:
https://www.marketinsightsreports.com/reports/01231062613/global-healthcare-microfluidics-market-insights-forecast-to-2025/inquiry?source=openpr&Mode=12

Regional Analysis For Healthcare Microfluidics Market:

For comprehensive understanding of market dynamics, the global Healthcare Microfluidics market is analyzed across key geographies namely:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Healthcare Microfluidics Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger and acquisitions along with trending innovation and business policies are reviewed in the report. The report contains basic, secondary and advanced information pertaining to the Market global status and trend, market size, share, growth, trends analysis, segment and forecasts from 2020-2026.

Following are major Table of Content of Healthcare Microfluidics Market:

- Global Market Overview, Drivers, Restraints and Opportunities, Segmentation overview
- Global Market competition by top Players
- Analysis by Regions
- Consumption by Regions
- Consumption, By Types, Revenue and Market share by Types
- Consumption, By Applications, Market share (%) and Growth Rate by Applications
- Complete profiling and analysis of Players
- Industrial Chain, Sourcing Strategy and Downstream Buyers
- Marketing Strategy Analysis, Distributors/Traders
- Global Market Effect Factors Analysis
- Global Market Forecast
- Global Market Research Findings and Conclusion, Appendix, methodology and data source

Finally, all aspects of the Global Market are quantitatively as well qualitatively assessed to study the Global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects. The report supplies the international economic competition with the assistance of Porter's Five Forces Analysis and SWOT Analysis.

For More Information On This Report, Please Visit:
https://www.marketinsightsreports.com/reports/01231062613/global-healthcare-microfluidics-market-insights-forecast-to-2025?source=openpr&Mode=12

We Offer Customization On Report Based On Specific Client Requirement:

- Free country Level analysis for any 5 countries of your choice.
- Free Competitive analysis of any 5 key market players.
- Free 40 analyst hours to cover any other data point.

Browse Related Reports:

Microfluidics Market:
https://bit.ly/2XzRgpE

Microfluidics Technology Market:
https://bit.ly/2K3HaW3

Microfluidics Device Market:
https://bit.ly/3bmEDTf

How we have factored the effect of Covid-19 in our report:
All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supplychain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

CONTACT US:
Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

ABOUT US:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.